Journal article
Endometrial cancer
Obstetrics and gynecology clinics of North America, Vol.39(2), pp.255-268
06/2012
DOI: 10.1016/j.ogc.2012.04.001
PMCID: PMC3518445
PMID: 22640714
Abstract
Despite the questions and barriers, the incorporation of molecular therapy into treatment regimens in endometrial cancer is an exciting area of investigation with the potential to improve outcomes. Outside of the development of a reliable screening test for endometrial cancer, converting the disease to a chronic state and improving progression-free survival is our best hope to reverse the concerning trend of decreasing 5-year survival for this disease.
Details
- Title: Subtitle
- Endometrial cancer
- Creators
- Kimberly K Leslie - Department of Obstetrics and Gynecology, University of Iowa, Iowa City, IA 52242, USA. kimberly-leslie@uiowa.eduKristina W ThielMichael J GoodheartKoen De GeestYichen JiaShujie Yang
- Resource Type
- Journal article
- Publication Details
- Obstetrics and gynecology clinics of North America, Vol.39(2), pp.255-268
- DOI
- 10.1016/j.ogc.2012.04.001
- PMID
- 22640714
- PMCID
- PMC3518445
- NLM abbreviation
- Obstet Gynecol Clin North Am
- ISSN
- 1558-0474
- eISSN
- 1558-0474
- Publisher
- United States
- Grant note
- R01 CA099908 / NCI NIH HHS CA27469 / NCI NIH HHS U10 CA027469 / NCI NIH HHS CA99908 / NCI NIH HHS
- Language
- English
- Date published
- 06/2012
- Academic Unit
- Pathology; Obstetrics and Gynecology
- Record Identifier
- 9983930471202771
Metrics
27 Record Views